Ohio State creates first gene chip for horse
...ork was supported in part by Affymetrix, Inc., the manufacturer of a variety of gene chips....Peregrine falcons may face new environmental threat
...Union beginning later this year, and the main U.S. manufacturer of the products recently announced its plans to phase out production of penta- and octa-BDEs as part of a voluntary agreement with the U.S. EPA. "We found high concentrations of all the different BDEs in both wild populations," says Cynthia de Wit, P...Best way to clean up toxic plumes? Give 'em a pill
...egreasers and solvents left over from nearly every manufacturer in the 1960s and '70s who made something from metal" he said. Schwartz conducted the study with David Li, a postdoctoral researcher in geology at Ohio State. Li presented the findings Wednesday in Anaheim at the meeting of the American Chemical Socie...Microarrays, key genome expression trackers, work better when probes are sequence-verified
...ions of the technology. They note that the leading manufacturer of such microarrays "apparentlyhas come to the same conclusion and has recently released a platform containing RefSeq-verified probes." Based on a comprehensive analysis of probe sequences on the 20 most common mammalian microarray platforms, the re...Flame retardant levels much higher in farmed salmon
...dants in the United States, although the main U.S. manufacturer recently announced plans to discontinue their use as part of a voluntary agreement with the U.S. EPA. The European Union has banned two types of PBDEs the penta and octa formulations and is currently considering a ban on the deca formulation. The A...Flame retardants found on supermarket shelves
...e fate of flame retardants, although the main U.S. manufacturer recently announced plans to discontinue production of the penta and octa formulations as part of a voluntary agreement with the U.S. EPA....Study explores gene transfer to modify underlying course of Alzheimer's disease
...ubsidiary of Cell Genesys, Inc.) the developer and manufacturer of CERE-110, is funding the study. Neurosurgery is required to precisely inject the drug into the nucleus basalis of Meynert on both sides of the brain. Dr. Roy Bakay, a Rush neurosurgeon and member of the Chicago Institute of Neurosurgery and Neu...